-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Lipocine, Raises Price Target to $15

Benzinga·01/21/2026 11:31:47
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains Lipocine (NASDAQ:LPCN) with a Buy and raises the price target from $7 to $15.